Medication abortion with misoprostol-only: A sample protocol

Abstract

Mifepristone approval by the United States (U.S.) Food and Drug Administration in 2000 revolutionized abortion care in this country. In 2020, 53% of people having facility-based abortions in the U.S. had medication abortions with mifepristone and misoprostol rather than uterine evacuation procedures [1]. A key advantage of medication abortion is that it can be provided entirely remotely by telemedicine and mail, which has been critical for patients who face barriers to accessing in-person services [2].